Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Kilbourn

Showing results (61-70 of 191) with videos related to

Pageof 20
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Simplifying the dosimetry of carbon-11-labeled radiopharmaceuticalsM C Wrobel, J E Carey, P S Sherman, et al.
Synapse (New York, N.Y.)|February 1, 1996
In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP)M R Kilbourn, S E Snyder, P S Sherman, et al.
Nuclear Medicine and Biology|May 1, 1996
Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transportersM R Kilbourn, K A Frey, T Vander Borght, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1987
Fluorine-18 labeling of proteinsM R Kilbourn, C S Dence, M J Welch, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 22, 1999
Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazineR A Koeppe, K A Frey, D E Kuhl, et al.
Chirality|January 1, 1997
Absolute configuration of (+)-alpha-dihydrotetrabenazine, an active metabolite of tetrabenazineM R Kilbourn, L C Lee, M J Heeg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 30, 2009
Signal separation and parameter estimation in noninvasive dual-tracer PET scans using reference-region approachesAniket D Joshi, Robert A Koeppe, Jeffrey A Fessler, et al.
Synapse (New York, N.Y.)|July 12, 2002
(R)-N-[11C]methyl-3-pyrrolidyl benzilate, a high-affinity reversible radioligand for PET studies of the muscarinic acetylcholine receptorMarc B Skaddan, Doug M Jewett, Phil S Sherman, et al.
Nuclear Medicine and Biology|March 30, 1999
Synthesis and evaluation of 6-[11C]methoxy-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-1,2- benzisoxazole as an in vivo radioligand for acetylcholinesteraseC Brown-Proctor, S E Snyder, P S Sherman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 15, 2001
Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptorsM B Skaddan, M R Kilbourn, S E Snyder, et al.
Pageof 20

Showing results (61-70 of 191) with videos related to

Sort By:
Pageof 20
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1997
Simplifying the dosimetry of carbon-11-labeled radiopharmaceuticalsM C Wrobel, J E Carey, P S Sherman, et al.
Synapse (New York, N.Y.)|February 1, 1996
In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdin-4-yl propionate ([11C]PMP)M R Kilbourn, S E Snyder, P S Sherman, et al.
Nuclear Medicine and Biology|May 1, 1996
Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transportersM R Kilbourn, K A Frey, T Vander Borght, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1987
Fluorine-18 labeling of proteinsM R Kilbourn, C S Dence, M J Welch, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 22, 1999
Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazineR A Koeppe, K A Frey, D E Kuhl, et al.
Chirality|January 1, 1997
Absolute configuration of (+)-alpha-dihydrotetrabenazine, an active metabolite of tetrabenazineM R Kilbourn, L C Lee, M J Heeg, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 30, 2009
Signal separation and parameter estimation in noninvasive dual-tracer PET scans using reference-region approachesAniket D Joshi, Robert A Koeppe, Jeffrey A Fessler, et al.
Synapse (New York, N.Y.)|July 12, 2002
(R)-N-[11C]methyl-3-pyrrolidyl benzilate, a high-affinity reversible radioligand for PET studies of the muscarinic acetylcholine receptorMarc B Skaddan, Doug M Jewett, Phil S Sherman, et al.
Nuclear Medicine and Biology|March 30, 1999
Synthesis and evaluation of 6-[11C]methoxy-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-1,2- benzisoxazole as an in vivo radioligand for acetylcholinesteraseC Brown-Proctor, S E Snyder, P S Sherman, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 15, 2001
Acetylcholinesterase inhibition increases in vivo N-(2-[18F]fluoroethyl)-4-piperidyl benzilate binding to muscarinic acetylcholine receptorsM B Skaddan, M R Kilbourn, S E Snyder, et al.
Pageof 20